Cargando…
Case series of COVID-19 in patients with myasthenia gravis: a single institution experience
Coronavirus disease 2019 (COVID-19), caused by the late 2019 outbreak of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a respiratory disease which could put myasthenia gravis patients at a greater risk of developing severe disease course. This paper presents a single-instituti...
Autores principales: | Županić, Sven, Perić Šitum, Martina, Majdak, Maja, Karakaš, Mirna, Bašić, Silvio, Sporiš, Davor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016150/ https://www.ncbi.nlm.nih.gov/pubmed/33797054 http://dx.doi.org/10.1007/s13760-021-01662-w |
Ejemplares similares
-
TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE
por: Županić, Sven, et al.
Publicado: (2021) -
Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al.
por: Galassi, Giuliana, et al.
Publicado: (2021) -
INCIDENCE OF ACUTE SYMPTOMATIC SEIZURES
IN PATIENTS WITH COVID-19: A SINGLE-CENTER STUDY
por: Šušak Sporiš, Ivana, et al.
Publicado: (2021) -
DELAYED EFFECT OF VNS ON INTERICTAL EPILEPTIFORM DISCHARGES AND PHARMACORESISTANCE IN A PATIENT WITH REFRACTORY PERINATAL POSTISCHEMIC EPILEPSY
por: Sporiš, Davor, et al.
Publicado: (2021) -
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)